Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
Abstract Background Drug repurposing is a swift, safe, and cheap drug discovery method. Melanoma disorders present low survival and high mortality rates and are challenging to diagnose and treat. Moreover, there is a high volume of worldwide investigations that are attempting to find melanoma-relate...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2019-06-01
|
| Sarja: | Molecular Medicine |
| Aiheet: | |
| Linkit: | http://link.springer.com/article/10.1186/s10020-019-0098-x |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|